▶ 調査レポート

世界のレビー小体型認知症薬市場：市場規模・現状・予測
• 英文タイトル：Global Lewy Body Dementia Drugs Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のレビー小体型認知症薬市場：市場規模・現状・予測 / Global Lewy Body Dementia Drugs Market Size, Status and Forecast 2019-2025 / QYR9N7450資料のイメージです。• レポートコード：QYR9N7450
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、104ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、レビー小体型認知症薬のグローバル市場について調査・分析したレポートで、種類別（モダフィニル、ベンゾジアゼピン、抗うつ薬、コリンエステラーゼ阻害剤、抗精神病薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・レビー小体型認知症薬の世界市場規模
・主要企業別市場シェア
・レビー小体型認知症薬の世界市場規模：種類別（モダフィニル、ベンゾジアゼピン、抗うつ薬、コリンエステラーゼ阻害剤、抗精神病薬、その他）
・レビー小体型認知症薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・レビー小体型認知症薬のアメリカ市場規模（種類別、用途別）
・レビー小体型認知症薬のヨーロッパ市場規模（種類別、用途別）
・レビー小体型認知症薬の中国市場規模（種類別、用途別）
・レビー小体型認知症薬の日本市場規模（種類別、用途別）
・レビー小体型認知症薬の東南アジア市場規模（種類別、用途別）
・レビー小体型認知症薬のインド市場規模（種類別、用途別）
・レビー小体型認知症薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・レビー小体型認知症薬の世界市場予測（2019年-2025年）
・レビー小体型認知症薬の地域別市場予測（2019年-2025年）
...

Lewy body dementia (LBD, sometimes referred to as Lewy body disorder) is an umbrella term that includes Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB), two dementias characterized by abnormal deposits of the protein alpha-synuclein in the brain.In 2018, the global Lewy Body Dementia Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lewy Body Dementia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lewy Body Dementia Drugs development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
Bayer
GlaxoSmithKline
Mylan
Sanofi
Johnson & Johnson
Teva Pharmaceuticals
Eli Lilly
Eisai
Takeda Pharmaceutical
Allergan
Bausch Health Companies
BioArctic
Sumitomo Dainippon Pharma
Jazz Pharmaceuticals
Hisamitsu Pharmaceutical

Market segment by Type, the product can be split into
Modafinil
Benzodiazepine
Antidepressants
Cholinesterase Inhibitors
Antipsychotic Drugs
Carbidopa-Levodopa

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lewy Body Dementia Drugs status, future forecast, growth opportunity, key market and key players.
To present the Lewy Body Dementia Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lewy Body Dementia Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lewy Body Dementia Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Modafinil
1.4.3 Benzodiazepine
1.4.4 Antidepressants
1.4.5 Cholinesterase Inhibitors
1.4.6 Antipsychotic Drugs
1.4.7 Carbidopa-Levodopa
1.5 Market by Application
1.5.1 Global Lewy Body Dementia Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lewy Body Dementia Drugs Market Size
2.2 Lewy Body Dementia Drugs Growth Trends by Regions
2.2.1 Lewy Body Dementia Drugs Market Size by Regions (2014-2025)
2.2.2 Lewy Body Dementia Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lewy Body Dementia Drugs Market Size by Manufacturers
3.1.1 Global Lewy Body Dementia Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Lewy Body Dementia Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lewy Body Dementia Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Lewy Body Dementia Drugs Key Players Head office and Area Served
3.3 Key Players Lewy Body Dementia Drugs Product/Solution/Service
3.4 Date of Enter into Lewy Body Dementia Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lewy Body Dementia Drugs Market Size by Type (2014-2019)
4.2 Global Lewy Body Dementia Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Lewy Body Dementia Drugs Market Size (2014-2019)
5.2 Lewy Body Dementia Drugs Key Players in United States
5.3 United States Lewy Body Dementia Drugs Market Size by Type
5.4 United States Lewy Body Dementia Drugs Market Size by Application

6 Europe
6.1 Europe Lewy Body Dementia Drugs Market Size (2014-2019)
6.2 Lewy Body Dementia Drugs Key Players in Europe
6.3 Europe Lewy Body Dementia Drugs Market Size by Type
6.4 Europe Lewy Body Dementia Drugs Market Size by Application

7 China
7.1 China Lewy Body Dementia Drugs Market Size (2014-2019)
7.2 Lewy Body Dementia Drugs Key Players in China
7.3 China Lewy Body Dementia Drugs Market Size by Type
7.4 China Lewy Body Dementia Drugs Market Size by Application

8 Japan
8.1 Japan Lewy Body Dementia Drugs Market Size (2014-2019)
8.2 Lewy Body Dementia Drugs Key Players in Japan
8.3 Japan Lewy Body Dementia Drugs Market Size by Type
8.4 Japan Lewy Body Dementia Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lewy Body Dementia Drugs Market Size (2014-2019)
9.2 Lewy Body Dementia Drugs Key Players in Southeast Asia
9.3 Southeast Asia Lewy Body Dementia Drugs Market Size by Type
9.4 Southeast Asia Lewy Body Dementia Drugs Market Size by Application

10 India
10.1 India Lewy Body Dementia Drugs Market Size (2014-2019)
10.2 Lewy Body Dementia Drugs Key Players in India
10.3 India Lewy Body Dementia Drugs Market Size by Type
10.4 India Lewy Body Dementia Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Lewy Body Dementia Drugs Market Size (2014-2019)
11.2 Lewy Body Dementia Drugs Key Players in Central & South America
11.3 Central & South America Lewy Body Dementia Drugs Market Size by Type
11.4 Central & South America Lewy Body Dementia Drugs Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lewy Body Dementia Drugs Introduction
12.1.4 Novartis Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lewy Body Dementia Drugs Introduction
12.2.4 Pfizer Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lewy Body Dementia Drugs Introduction
12.3.4 Bayer Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lewy Body Dementia Drugs Introduction
12.4.4 GlaxoSmithKline Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Mylan
12.5.1 Mylan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lewy Body Dementia Drugs Introduction
12.5.4 Mylan Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.5.5 Mylan Recent Development
12.6 Sanofi
12.6.1 Sanofi Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lewy Body Dementia Drugs Introduction
12.6.4 Sanofi Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.6.5 Sanofi Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lewy Body Dementia Drugs Introduction
12.7.4 Johnson & Johnson Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 Teva Pharmaceuticals
12.8.1 Teva Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lewy Body Dementia Drugs Introduction
12.8.4 Teva Pharmaceuticals Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.8.5 Teva Pharmaceuticals Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lewy Body Dementia Drugs Introduction
12.9.4 Eli Lilly Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.9.5 Eli Lilly Recent Development
12.10 Eisai
12.10.1 Eisai Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lewy Body Dementia Drugs Introduction
12.10.4 Eisai Revenue in Lewy Body Dementia Drugs Business (2014-2019)
12.10.5 Eisai Recent Development
12.11 Takeda Pharmaceutical
12.12 Allergan
12.13 Bausch Health Companies
12.14 BioArctic
12.15 Sumitomo Dainippon Pharma
12.16 Jazz Pharmaceuticals
12.17 Hisamitsu Pharmaceutical

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Lewy Body Dementia Drugs Key Market Segments
Table Key Players Lewy Body Dementia Drugs Covered
Table Global Lewy Body Dementia Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lewy Body Dementia Drugs Market Size Market Share by Type 2014-2025
Figure Modafinil Figures
Table Key Players of Modafinil
Figure Benzodiazepine Figures
Table Key Players of Benzodiazepine
Figure Antidepressants Figures
Table Key Players of Antidepressants
Figure Cholinesterase Inhibitors Figures
Table Key Players of Cholinesterase Inhibitors
Figure Antipsychotic Drugs Figures
Table Key Players of Antipsychotic Drugs
Figure Carbidopa-Levodopa Figures
Table Key Players of Carbidopa-Levodopa
Table Global Lewy Body Dementia Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Lewy Body Dementia Drugs Report Years Considered
Table Global Lewy Body Dementia Drugs Market Size 2014-2025 (Million US$)
Figure Global Lewy Body Dementia Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lewy Body Dementia Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Lewy Body Dementia Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Lewy Body Dementia Drugs Market Share by Regions 2014-2019
Figure Global Lewy Body Dementia Drugs Market Share by Regions 2014-2019
Figure Global Lewy Body Dementia Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Lewy Body Dementia Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lewy Body Dementia Drugs Market Share by Manufacturers (2014-2019)
Figure Global Lewy Body Dementia Drugs Market Share by Manufacturers in 2018
Table Global Lewy Body Dementia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lewy Body Dementia Drugs Product/Solution/Service
Table Date of Enter into Lewy Body Dementia Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lewy Body Dementia Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Lewy Body Dementia Drugs Market Size Share by Type (2014-2019)
Figure Global Lewy Body Dementia Drugs Market Size Market Share by Type (2014-2019)
Table Global Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Lewy Body Dementia Drugs Market Size Share by Application (2014-2019)
Figure Global Lewy Body Dementia Drugs Market Size Market Share by Application (2014-2019)
Figure Global Lewy Body Dementia Drugs Revenue Market Share by Application in 2018
Figure United States Lewy Body Dementia Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Lewy Body Dementia Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Lewy Body Dementia Drugs Market Share (2018-2019)
Table United States Lewy Body Dementia Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Lewy Body Dementia Drugs Market Share by Type (2014-2019)
Table United States Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Lewy Body Dementia Drugs Market Share by Application (2014-2019)
Figure Europe Lewy Body Dementia Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Lewy Body Dementia Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Lewy Body Dementia Drugs Market Share (2018-2019)
Table Europe Lewy Body Dementia Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Lewy Body Dementia Drugs Market Share by Type (2014-2019)
Table Europe Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Lewy Body Dementia Drugs Market Share by Application (2014-2019)
Figure China Lewy Body Dementia Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Lewy Body Dementia Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Lewy Body Dementia Drugs Market Share (2018-2019)
Table China Lewy Body Dementia Drugs Market Size by Type (2014-20189) (Million US$)
Table China Lewy Body Dementia Drugs Market Share by Type (2014-2019)
Table China Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table China Lewy Body Dementia Drugs Market Share by Application (2014-2019)
Figure Japan Lewy Body Dementia Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Lewy Body Dementia Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Lewy Body Dementia Drugs Market Share (2018-2019)
Table Japan Lewy Body Dementia Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Lewy Body Dementia Drugs Market Share by Type (2014-2019)
Table Japan Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Lewy Body Dementia Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Lewy Body Dementia Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lewy Body Dementia Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lewy Body Dementia Drugs Market Share (2018-2019)
Table Southeast Asia Lewy Body Dementia Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lewy Body Dementia Drugs Market Share by Type (2014-2019)
Table Southeast Asia Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lewy Body Dementia Drugs Market Share by Application (2014-2019)
Figure India Lewy Body Dementia Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Lewy Body Dementia Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Lewy Body Dementia Drugs Market Share (2018-2019)
Table India Lewy Body Dementia Drugs Market Size by Type (2014-2019) (Million US$)
Table India Lewy Body Dementia Drugs Market Share by Type (2014-2019)
Table India Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table India Lewy Body Dementia Drugs Market Share by Application (2014-2019)
Figure Central & South America Lewy Body Dementia Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lewy Body Dementia Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lewy Body Dementia Drugs Market Share (2018-2019)
Table Central & South America Lewy Body Dementia Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lewy Body Dementia Drugs Market Share by Type (2014-2019)
Table Central & South America Lewy Body Dementia Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lewy Body Dementia Drugs Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Lewy Body Dementia Drugs Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Bayer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Mylan Company Details
Table Mylan Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Mylan Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table Eisai Company Details
Table Eisai Revenue in Lewy Body Dementia Drugs Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Lewy Body Dementia Drugs Business (2014-2019)
Table Eisai Recent Development
Table Takeda Pharmaceutical Company Details
Table Allergan Company Details
Table Bausch Health Companies Company Details
Table BioArctic Company Details
Table Sumitomo Dainippon Pharma Company Details
Table Jazz Pharmaceuticals Company Details
Table Hisamitsu Pharmaceutical Company Details
Table Global Lewy Body Dementia Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Lewy Body Dementia Drugs Market Size Share by Regions (2019-2025)
Figure Global Lewy Body Dementia Drugs Market Size Share by Regions in 2025
Figure United States Lewy Body Dementia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lewy Body Dementia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Lewy Body Dementia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lewy Body Dementia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lewy Body Dementia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Lewy Body Dementia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lewy Body Dementia Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Lewy Body Dementia Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Lewy Body Dementia Drugs Market Size by Product (2019-2025)
Figure Global Lewy Body Dementia Drugs Market Size by Product in 2025
Table Global Lewy Body Dementia Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Lewy Body Dementia Drugs Market Size by Application (2019-2025)
Figure Global Lewy Body Dementia Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のアルツハイマー病に関連する認知症市場：市場規模・現状・予測
    Global Dementia Associated with Alzimer’s Disease Market Size, Status and Forecast 2019-2025
    QYR9N7075 2019年6月14日 96Pages
    当資料は、アルツハイマー病に関連する認知症のグローバル市場について調査・分析したレポートで、種類別（コリン作動性/コリンエステラーゼ（ChE）阻害剤、メマンチン、配合薬（メマンチン＆ドネペジル）、その他）、用途別（病院薬局、小売、オンライン販売）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南ア...
  • 世界の多発性梗塞性認知症市場：市場規模・現状・予測
    Global Multi-Infarct Dementia Market Size, Status and Forecast 2019-2025
    QYR9N7599 2019年6月14日 99Pages
    当資料は、多発性梗塞性認知症のグローバル市場について調査・分析したレポートで、種類別（薬理学的治療、非薬理学的治療）、用途別（学術、病院、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界の全身イメージング市場：市場規模・現状・予測
    Global Whole-Body Imaging Market Size, Status and Forecast 2019-2025
    QYR9N8196 2019年6月14日 92Pages
    当資料は、全身イメージングのグローバル市場について調査・分析したレポートで、種類別（コンピュータ断層撮影スキャン、陽電子放出断層撮影スキャン）、用途別（病院、診断センター、専門クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の患者体温モニタリング市場：市場規模・現状・予測
    Global Patient Body Temperature Monitoring Market Size, Status and Forecast 2019-2025
    QYR9N7774 2019年6月14日 96Pages
    当資料は、患者体温モニタリングのグローバル市場について調査・分析したレポートで、種類別（非侵襲的温度モニタリング、侵襲的温度モニタリング）、用途別（病院と診療所、介護施設、在宅ケア、外来治療センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場...
  • 世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測
    Global Non Cataplexy Narcolepsy Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7681 2019年6月14日 93Pages
    当資料は、非カタプレキシーナルコレプシー薬のグローバル市場について調査・分析したレポートで、種類別（抗酸化薬、覚せい剤、その他）、用途別（子供（18歳未満）、成人（18〜50歳）、高齢者（50歳以上）、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...
  • 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測
    Global Myelodysplastic Syndrome (MDS) Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7611 2019年6月14日 96Pages
    当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の凍結乾燥注射薬市場：市場規模・現状・予測
    Global Lyophilized Injectable Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7487 2019年6月14日 96Pages
    当資料は、凍結乾燥注射薬のグローバル市場について調査・分析したレポートで、種類別（使い捨てバイアル、ポイントオブケア再構成、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の鼻出血薬市場：市場規模・現状・予測
    Global Epistaxis Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7169 2019年6月14日 99Pages
    当資料は、鼻出血薬のグローバル市場について調査・分析したレポートで、種類別（血管収縮薬、麻酔薬、抗生物質軟膏、焼灼剤、その他）、用途別（病院、診療所、小売薬局、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界のテネクテプラーゼ薬市場：市場規模・現状・予測
    Global Tenecteplase Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8112 2019年6月14日 93Pages
    当資料は、テネクテプラーゼ薬のグローバル市場について調査・分析したレポートで、種類別（静脈内投与量、カテーテル内点滴注入量）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...
  • 世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測
    Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8151 2019年6月14日 99Pages
    当資料は、チロシンヒドロキシラーゼ欠乏薬のグローバル市場について調査・分析したレポートで、種類別（トリヘキシフェニジル、アマンタジン、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界のアルツハイマー病に関連する認知症市場：市場規模・現状・予測世界のアルツハイマー病に関連する認知症市場：市場規模・現状・予測 The global dementia associated with Alzheimer’s disease market has been segmented based on drug class and distribution channel. In terms of drug class, the global market has been classified into cholinergic/ cholinesterase (ChE) inhibitor, memantine, and combined drug (memantine & donepezil) and oth…
  • 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …
  • 世界の一般的な腫瘍治療薬市場：市場規模・現状・予測世界の一般的な腫瘍治療薬市場：市場規模・現状・予測 In 2018, the global Generic Oncology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key playe…
  • 世界の神経因性疼痛治療薬市場：市場規模・現状・予測世界の神経因性疼痛治療薬市場：市場規模・現状・予測 Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).In terms of value, North America is a large market and is expected to …
  • 世界の鼻出血薬市場：市場規模・現状・予測世界の鼻出血薬市場：市場規模・現状・予測 A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils.Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to cr…